Purely visual-interactive analytics to answer virtually any question without coding, cleaning, or queries.
Get to meaningful insights 10x-100x faster than any other technology.
Interact with your data at any scale to see the big picture or drill down to even the smallest detail.
The term "visual analytics" is overused in this space. Helynx is what visual analytics should be.
Growth Advisor, Investor, Technologist
There are a lot of algorithms out there, but I don't think they there's any tool that ties it all together with this level of sophistication.
Fred Mixon, MD
former Chief Medical Officer
Sacred Heart Medical Group
"Helynx enables the user to bring clinical understanding to complex data. This means scarce resources may be devoted to those who will benefit the most."
Marjorie Schulman, MD
Assoc. Professor of Population Health
NYU School of Medicine
"We believe that analytics will play a transformative role in healthcare in the near future and especially in population health management. Helynx's unique platform will help us further identify our highest risk patients so we can assign care managers and clinicians to them and intervene in their care before they deteriorate," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "These interventions should significantly reduce avoidable hospitalizations, improve patient outcomes and save millions of dollars in healthcare costs."
Helynx wins first prize for our solution to increase patient enrollment in clinical trials in the Ideation Phase of the Herox Clinical Trials Innovation Challenge sponsored by the Bonnie J. Addario Lung Cancer Foundation.
Helynx moves in to idealab.
Thanks to everyone who voted! If you haven't already, check out the video describing our solution our solution to the problem of recruiting more patients for clinical trials.
Boris successfully defends his Ph.D. Congratulations, Boris!
Helynx and Dr. Jae Kim enter the Herox Clinical Trial Innovation Prize challenge, with a plan to dramatically increase patient recruitment in clinical trials.
Helynx gives a talk for Caltech's CNS program.
Helynx invited to Rock Health CEO Summit on Digital Health.
Helynx technology presented at the Second Annual Summit on Risk Adjustment And Revenue Management for the Health Insurance Exchanges, in Carlsbad, CA.
Our co-founder, in the Wall Street Journal: "...a crowbar to pry open how the brain works."
Our non-profit text-messaging project was featured in Harvard Magazine. "...a system that allows U.S.-based surgeons to follow up with their patients in Africa..."
Helynx was created by a group of neuroscientists from Caltech and Harvard.
Chess Stetson, Ph.D., did his doctoral (2012) and post-doctoral work in Computation and Neural Systems at Caltech, studying the oscillatory relationship between cortical regions and using signals from individual neurons to predict decisions. Previously, he studied the basis of neural time processing. He earned an AB in Physics from Harvard College, (2001) and an MS from the University of Texas (Houston Medical Center, 2006). He also worked as an engineer at MIT Lincoln Laboratory and the Smithsonian Astrophysical Observatory, building instrumentation for air- and rocket-borne experiments. And, he has appeared several times as a neuroscience expert on National Geographic.
Boris Revechkis received his PhD (2015) in Computation and Neural Systems from Caltech. There, Boris investigated the use of the parietal lobe for neural prosthetics, a.k.a. brain-machine interfaces, examining the role of parietal areas in motor function and self-monitoring. These experiments allowed paralyzed patients to control avatars in 3D virtual reality directly with their neurons, i.e. just by thinking about it, and represent the first ever clinical trials of a neural prosthesis controlled by the parietal lobe. Previously, Boris learned about reverse engineering the brain at New York University where he completed his BSc in Neural Science (2008) and developed software for a personal finance startup.
Kris (Ph.D. 2008, Particle Physics, Harvard) has a stellar scientific track record and statistical background, publishing on topics ranging from rare decays of exotic subatomic particles to neural computation to the neuroscience of baseball. He earned an AB in Physics from Harvard College in 2001, and among his awards are fellowships from the Sloan foundation, Gatsby foundation and NSF.
Dr. Kearns is the Managing Partner for 2K Healthcare Solution, and Quality/ Transformation Physician Leader for Atlanticare Health System, Inc., where he leverages industry leading expertise in medical management, operations, and data analytics to provide clinical program development, care management and comprehensive medical expense management solutions to health systems, managed care organizations, and technology companies.
Founder of GoTo.com, Intranets.com, and X1 Technologies among others. Extensive, long-standing ties to Caltech, Idealab, Innovate Pasadena, Art Center, JPL and the broader Pasadena start-up community. Managing director of Mt. Wilson Ventures.
Financing, growth, M&A and restructuring experience with a diverse set of companies and institutions including MOCA, LiveGamer, Adapt Technologies, Weil Publishing, GiftCertificates.com, Tokai Bank Europe, and The MAC Group. Managing director of Mt. Wilson Ventures.
Want to learn more or schedule a demo?